Skip to search.
 FTSE 100 Up 0.33%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
6.09 Up 0.04(0.66%) 9 Dec 21:00
Prev Close:6.05
Open:6.11
Bid:5.91 x 700
Ask:6.28 x 1000
1y Target Est:10.94
Beta:1.51221
Earnings Date:24 Feb - 28 Feb (Est.)
Day's Range:5.98 - 6.43
52wk Range:4.98 - 9.99
Volume:2,341,316
Avg Vol (3m):2,520,190
Market Cap:866.77m
P/E (ttm):N/A
EPS (ttm):-1.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for FOLD at this time.

Comparison

Symbol% ChgMkt Cap
FOLDUp 0.66%866.77m
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):404.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.40
Quarterly EPS Est (Dec-16) :-0.34
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback